Table 3.
Group | Met (μM/L) | Hcy (μM/L) | Cys (μM/L) | Tau (μM/L) | Ser (μM/L) | Gly (μM/L) | GSH (μM/L) |
---|---|---|---|---|---|---|---|
Control | 75.7 ± 4.7 | 3.4 ± 0.6 | 29.7 ± 6.7 | 344.4 ± 37.6 | 316.9 ± 42.8 | 426.3 ± 79.9 | 25.6 ± 5.7 |
0.5% Q | 68.4 ± 2.0 | 3.7 ± 0.4 | 57.0 ± 14.2∗ | 413.9 ± 15.2∗ | 287.4 ± 64.7 | 385.0 ± 89.3 | 20.3 ± 3.1∗ |
1.0% Met | 68.4 ± 5.4 | 5.8 ± 1.1∗§ | 67.0 ± 9.0∗§ | 454.0 ± 46.3∗ | 285.5 ± 27.6 | 419.6 ± 63.9 | 30.4 ± 3.3∗§ |
1.0% Met/0.5% Q | 69.0 ± 0.7 | 4.2 ± 0.7≠ | 66.8 ± 3.9∗§ | 505.0 ± 31.2∗§≠ | 220.8 ± 22.8∗§≠ | 350.3 ± 66.6∗≠ | 21.4 ± 2.5≠ |
Met, methionine; Hcy, homocysteine; Cys, cysteine; Tau, taurine; Ser, serine; Gly, glycine; GSH, reduced glutathione; 0.5% Q, 0.5% quercetin supplemented group; 1.0% Met, 1.0% Met supplemented group; 1.0% Met/0.5% Q, 1.0% Met plus 0.5% quercetin supplemented group.
Results are expressed as mean and standard deviation (n = 8). ∗Significantly different from the control group (p < 0.05). §Significantly different from the 0.5% Q group (p < 0.05). ≠Significantly different from the 1.0% Met group (p < 0.05).